Global Acute Migraine Drugs Market - Covid-19 Impact and Forecast (2023-2028)

Analysis By Drug Type (Ergot Alkaloids, Analgesics, Triptans, Others), Route of Administration, Availability, By Region, By Country: Market Size, Insights, Competition,

Published	Pages	Publisher	Report code
Feb 2023	260	Azoth Analytics	ASDR-616930

Published: Feb 2023 - Pages : 260 - Publisher : Azoth Analytics - Report code : ASDR-616930

Eli Lilly and Company
GSK plc. Bayer AG
Johnson & Johnson
Teva Pharmaceutical Industries Ltd. AbbVie Inc. Novartis
Merck & Co. Inc. Pfizer Inc. Boehringer Ingelheim.

Global Migraine Drugs Market - 2024-2031

This report can be of interest as well:

Global Migraine Drugs Market - 2024-2031

Published: March, 2025 | Report code: ASDR-674534